Concomitant external pneumatic compression treatment with consecutive days of high intensity interval training reduces markers of proteolysis

Haun, Cody T.; Roberts, Michael D.; Romero, Matthew A.; Osburn, Shelby C.; Healy, James C.; Moore, Angelique N.; Mobley, C. Brooks; Roberson, Paul A.; Kephart, Wesley C.; Mumford, Petey W.; Goodlett, Michael D.; Pascoe, David D.; Martin, Jeffrey S.

doi:10.1007/s00421-017-3746-2

Cited by 9 publications

(24 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is consistent with the present study, where VAS showed a sharp increase in the first 24 h and a very mild increase after 48 h in all groups. There was no difference in VAS increase with INP or IPC after 24 or 48 h. Most previous research yielded no statistically significant results, with no differences after applying IPC [ 24 , 26 , 27 ]. Fonda et al (2015) described an improvement in VAS after INP, while van Rensburg et al (2017) found no difference, similar to the present study [ 12 , 13 ].…”

Section: Discussionmentioning

confidence: 71%

“…No difference was observed between groups. Most previous research also identified no difference in CK levels using compression [ 23 , 24 ] or negative pressure [ 12 , 13 ]. A recent study demonstrated a more significant CK decrease after INP than after active recovery therapy.…”

Section: Discussionmentioning

confidence: 99%

“…The improved perfusion helps remove excess lactate but does not improve anaerobic performance [ 9 ]. Acute administration of IPC significantly upregulates PGC‐1α gene expression (by 77%) after 1 h following therapy, improving the muscle tissue's neovascularization [ 24 ]. Despite these theoretical benefits, it may be hypothesized that the intervention time is too short to yield any significant benefits, given that 30 min a day is only approximately 2% of the day.…”

Section: Discussionmentioning

confidence: 99%

“…If the improved perfusion only occurs during the procedure, this period may be too short for any meaningful impact. Haun et al (2017) applied IPC for 1 h periods and Northey et al for 45 min, and neither observed any differences between IPC and control groups [ 24 , 27 ]. Therefore, the application would need to be even longer if this hypothesis was true, which would be impractical, given that the limbs are immobilized for the duration of the treatment.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

The efficacy of intermittent pneumatic compression and negative pressure therapy on muscle function, soreness and serum indices of muscle damage: a randomized controlled trial

Wiecha

Jarocka

Wiśniowski

et al. 2021

BMC Sports Sci Med Rehabil

View full text Add to dashboard Cite

Background The study aimed to assess whether intermittent pneumatic compression (IPC) and intermittent negative pressure (INP) would attenuate the muscle damaging effects of eccentric exercise. Methods Forty-five healthy males were recruited. Immediately post, 24 and 48 h post eccentric exercise consisting of 100 drop jumps, volunteers randomly received 30-min sessions of intermittent pneumatic compression (IPC, n = 15) or intermittent negative pressure (INP, n = 15), or sham microcurrent (PT, n = 15). Creatine kinase (CK), lactate dehydrogenase (LDH), isokinetic muscle strength, soreness and active flexion of the knee joint were measured after every therapy session. Results No significant intergroup differences were observed in biochemical or functional measurements. However, there was an increase in muscle soreness (P < 0.05), CK and LDH activity (P < 0.05), and a reduction in muscle strength (P < 0.05) and range of active knee flexion (P < 0.05). Conclusions The prescription of IPC and INP did not attenuate the reduction of markers to muscle function or pain perception up to 48 h after muscle damaging exercise. Future research should focus on the potential impact of treatment frequency and duration on muscle recovery. Trial registration The study was retrospectively registered in the Australian New Zealand Clinical Trials Registry (ANZCTR); The trial registration number: ACTRN12621001294842; date of registration: 24/09/2021.

show abstract

Section: Discussionmentioning

confidence: 71%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The efficacy of intermittent pneumatic compression and negative pressure therapy on muscle function, soreness and serum indices of muscle damage: a randomized controlled trial

Wiecha

Jarocka

Wiśniowski

et al. 2021

BMC Sports Sci Med Rehabil

View full text Add to dashboard Cite

show abstract

“…One study included strength-trained males [26]. Two studies included physically active volunteers [30] [18] and athletes [31] [32], another two studies chose healthy participants [19] [27]. Detailed information about the training status is presented in the Table 1.…”

Section: Details Of the Intervention Groups In The Included Studiesmentioning

confidence: 99%

The Effect of Pressotherapy on Performance and Recovery in the Management of Delayed Onset Muscle Soreness: A Systematic Review and Meta-Analysis

Wiśniowski¹,

Cieśliński²,

Jarocka³

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: It has been demonstrated that pressotherapy used post-exercise (Po-E) can influence training performance, recovery, and physiological properties. This study examined the effec-tiveness of pressotherapy on these parameters. Methods: The systematic review and meta-analysis were performed according to PRISMA guidelines. A literature search of MEDLINE, PubMed, EBSCO, Web of Science, SPORTDiscus and ClinicalTrials has been done up to March 2021. Inclusion criteria were: randomized control trials (RCTs) or cross-over studies, mean participant age be-tween 18-65 yrs., ≥ 1 exercise mechanical pressotherapy intervention. The risk of bias was assessed by the Cochrane risk-of-bias tool for RCT (RoB 2.0). Results: 12 studies comprised of 322 partici-pants have been selected. The mean sample size was n = 25. Pressotherapy significantly reduce muscle soreness(Standard Mean Difference;SMD= -0.33; CI = -0.49, -0.18; p < 0.0001; I2 = 7%). Pres-sotherapy did not significantly affect jump height (SMD = -0.04; CI =-0.36, -0.29; p = 0.82). Presso-therapy did not significantly affect creatine kinase level 24-96h after DOMS induction (SMD = 0.41; CI = -0.07, 0.89; p = 0.09; I2 = 63%). Conclusions: Only moderate benefits of using pressotherapy as a recovery intervention have been observed. Results varied between the type of exercise and used protocol. Pressotherapy should only be applied as an additional component of a more compre-hensive recovery strategy. Study PROSPERO registration number- CRD42020189382.

show abstract

Skeletal muscle amino acid transporter and BCAT2 expression prior to and following interval running or resistance exercise in mode-specific trained males

et al. 2018

View full text Add to dashboard Cite

Endurance (END)- and resistance (RES)-trained males performed interval running or resistance exercise during three consecutive days (bouts 1-3). Muscle biopsies were obtained at baseline, 2 h post-bout 1, and 72 h post-bout 3. Amino acid transporter SNAT2 mRNA was 75% greater in END (group p = 0.008), and increased ~ 70% 2 h post in both groups (time p = 0.023). Amino acid transporter PAT1 mRNA was 2.7-fold greater in RES (group p = 0.002). Baseline protein levels of the mitochondrial aminotransferase BCAT2 were 79% greater in END (p = 0.015).

show abstract

Concomitant external pneumatic compression treatment with consecutive days of high intensity interval training reduces markers of proteolysis

Abstract: EPC when used concurrently with HIIT and in subsequent recovery days reduces skeletal muscle markers of proteolysis.

Cited by 9 publications

References 35 publications

The efficacy of intermittent pneumatic compression and negative pressure therapy on muscle function, soreness and serum indices of muscle damage: a randomized controlled trial

The efficacy of intermittent pneumatic compression and negative pressure therapy on muscle function, soreness and serum indices of muscle damage: a randomized controlled trial

The Effect of Pressotherapy on Performance and Recovery in the Management of Delayed Onset Muscle Soreness: A Systematic Review and Meta-Analysis

Skeletal muscle amino acid transporter and BCAT2 expression prior to and following interval running or resistance exercise in mode-specific trained males

Contact Info

Product

Resources

About